The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Stimulation of the p38 Mitogen-activated Protein Kinase Pathway in Neonatal Rat Ventricular Myocytes by the G Protein–coupled Receptor Agonists, Endothelin-1 and Phenylephrine: A Role in Cardiac Myocyte Hypertrophy?
Open accessAbstract
We examined the activation of the p38 mitogen-activated protein kinase (p38-MAPK) pathway by the G protein–coupled receptor agonists, endothelin-1 and phenylephrine in primary cultures of cardiac myocytes from neonatal rat hearts. Both agonists increased the phosphorylation (activation) of p38-MAPK by ∼12-fold. A p38-MAPK substrate, MAPK-activated protein kinase 2 (MAPKAPK2), was activated approximately fourfold and 10 μM SB203580, a p38-MAPK inhibitor, abolished this activation. Phosphorylation of the MAPKAPK2 substrate, heat shock protein 25/27, was also increased. Using selective inhibitors, activation of the p38-MAPK pathway by endothelin-1 was shown to involve protein kinase C but not Gi/Go nor the extracellularly responsive kinase (ERK) pathway. SB203580 failed to inhibit the morphological changes associated with cardiac myocyte hypertrophy induced by endothelin-1 or phenylephrine between 4 and 24 h. However, it decreased the myofibrillar organization and cell profile at 48 h. In contrast, inhibition of the ERK cascade with PD98059 prevented the increase in myofibrillar organization but not cell profile. These data are not consistent with a role for the p38-MAPK pathway in the immediate induction of the morphological changes of hypertrophy but suggest that it may be necessary over a longer period to maintain the response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., & Loriolle, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98476-0 · Cited by 2,456
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)00357-f · Cited by 2,086
Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T., & Nebreda, A. R. (1994) · Cell · doi:10.1016/0092-8674(94)90277-1 · Cited by 1,674
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Rubanyi, G. M., & Polokoff, M. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06809-7 · Cited by 1,654
Cited by
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Chen, Z., Gibson, T. B., Robinson, F., Silvestro, L., Pearson, G., Xu, B.-E., Wright, A., Vanderbilt, C., & Cobb, M. H. (2001) · Chemical Reviews · doi:10.1021/cr000241p · Cited by 788
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn II, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 689
Adrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
Lu, J., McKinsey, T. A., Nicol, R. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080064097 · Cited by 518
Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular Development
Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R., & Nebreda, A. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00014-6 · Cited by 516
Sugden, P. H., & Clerk, A. (1998) · Circulation Research · doi:10.1161/01.res.83.4.345 · Cited by 513
Self-citationIschemic Preconditioning: From Adenosine Receptor to KATP Channel
Cohen, M. V., Baines, C. P., & Downey, J. M. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.79 · Cited by 475
Crisostomo, P. R., Wang, Y., Markel, T. A., Wang, M., Lahm, T., & Meldrum, D. R. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00437.2007 · Cited by 459
Regulation of Blood Pressure and Salt Homeostasis by Endothelin
Kohan, D. E., Rossi, N. F., Inscho, E. W., & Pollock, D. M. (2011) · Physiological Reviews · doi:10.1152/physrev.00060.2009 · Cited by 433
The complexity of mitogen-activated protein kinases (MAPKs) made simple
Krishna, M., & Narang, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8170-7 · Cited by 432
Involvement of Extracellular Signal-Regulated Kinases 1/2 in Cardiac Hypertrophy and Cell Death
Bueno, O. F., & Molkentin, J. D. (2002) · Circulation Research · doi:10.1161/01.res.0000038488.38975.1a · Cited by 397
Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y.-S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17295 · Cited by 332
17β-Estradiol Attenuates the Development of Pressure-Overload Hypertrophy
van Eickels, M., Grohé, C., Cleutjens, J. P. M., Janssen, B. J., Wellens, H. J. J., & Doevendans, P. A. (2001) · Circulation · doi:10.1161/hc3601.095577 · Cited by 300
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
Taigen, T., De Windt, L. J., Lim, H. W., & Molkentin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1196 · Cited by 294
Adenosine 5′-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Vassort, G. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.767 · Cited by 276
Liang, Q., Wiese, R. J., Bueno, O. F., Dai, Y.-S., Markham, B. E., & Molkentin, J. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7460-7469.2001 · Cited by 271
Cardiac oxidative stress in acute and chronic isoproterenol-infused rats
ZHANG, G., KIMURA, S., NISHIYAMA, A., SHOKOJI, T., RAHMAN, M., YAO, L., NAGAI, Y., FUJISAWA, Y., MIYATAKE, A., & ABE, Y. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.013 · Cited by 268
Regulation of Mitogen-Activated Protein Kinase Signaling Networks by G Protein-Coupled Receptors
Gutkind, J. S. (2000) · Science's STKE · doi:10.1126/stke.2000.40.re1 · Cited by 264
p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α
Barger, P. M., Browning, A. C., Garner, A. N., & Kelly, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105945200 · Cited by 260
Papaconstantinou, J. (2019) · Cells · doi:10.3390/cells8111383 · Cited by 258
Fernandez-Twinn, D. S., Blackmore, H. L., Siggens, L., Giussani, D. A., Cross, C. M., Foo, R., & Ozanne, S. E. (2012) · Endocrinology · doi:10.1210/en.2012-1508 · Cited by 141
Metadata
- Authors
- Clerk, A., Michael, A., & Sugden, P. H.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 1998-07-27
- Volume
- 142
- Issue
- 2
- Pages
- 523-535
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2150200572
- Cited by
- 308
- References
- 62
- FWCI
- 24.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.